Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
NCT ID:
NCT02031432
Population Description:
Participants who completed treatment in KF6005/07 started on a daily dose of 200 or 400 μg (depending on previous dose level) in KF6005/09. The treatment code from KF6005/07 was not unblinded at the time of cebranopadol treatment initiation in KF6005/09, and in this trial all participants were titrated to their optimal dose of cebranopadol.
Study:
NCT02031432
Study Brief:
Results Section:
NCT02031432